These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21844988)

  • 1. A brief review on recent developments in animal models of schizophrenia.
    Trivedi MS; Jarbe T
    Indian J Pharmacol; 2011 Jul; 43(4):375-80. PubMed ID: 21844988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models with construct validity for schizophrenia.
    Ellenbroek BA; Cools AR
    Behav Pharmacol; 1990; 1(6):469-490. PubMed ID: 11175433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients.
    Swerdlow NR; Braff DL; Taaid N; Geyer MA
    Arch Gen Psychiatry; 1994 Feb; 51(2):139-54. PubMed ID: 8297213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological treatment of schizophrenia: what do we have, and what could we get?
    Ellenbroek BA
    Neuropharmacology; 2012 Mar; 62(3):1371-80. PubMed ID: 21420988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are schizophrenic patients being told their diagnosis today in France?].
    Villani M; Kovess-Masféty V
    Encephale; 2017 Apr; 43(2):160-169. PubMed ID: 27372353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Schizophrenia diagnostic announcement in a French psychiatric unit].
    Rocamora JF; Benadhira R; Saba G; Stamatadis L; Kalalaou K; Dumortier G; Plaze M; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2005; 31(4 Pt 1):449-55. PubMed ID: 16389712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptors and schizophrenia: contribution of molecular genetics and clinical neuropsychology.
    Emilien G; Maloteaux JM; Geurts M; Owen MJ
    Int J Neuropsychopharmacol; 1999 Sep; 2(3):197-227. PubMed ID: 11281990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer atypical antipsychotic medication versus clozapine for schizophrenia.
    Tuunainen A; Wahlbeck K; Gilbody SM
    Cochrane Database Syst Rev; 2000; (2):CD000966. PubMed ID: 10796559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
    Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
    Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing roles and targets for animal models of schizophrenia.
    Kilts CD
    Biol Psychiatry; 2001 Dec; 50(11):845-55. PubMed ID: 11743940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsomatic treatment of depression.
    Sherrill JT; Kovacs M
    Child Adolesc Psychiatr Clin N Am; 2002 Jul; 11(3):579-93. PubMed ID: 12222084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive endophenotypes, gene-environment interactions and experience-dependent plasticity in animal models of schizophrenia.
    Burrows EL; Hannan AJ
    Biol Psychol; 2016 Apr; 116():82-9. PubMed ID: 26687973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring Medication Adherence in Patients With Schizophrenia: An Integrative Review.
    Bright CE
    Arch Psychiatr Nurs; 2017 Feb; 31(1):99-110. PubMed ID: 28104068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse pharmacological models of cognitive disruption relevant to schizophrenia.
    Young JW; Powell SB; Geyer MA
    Neuropharmacology; 2012 Mar; 62(3):1381-90. PubMed ID: 21726569
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.